➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
McKesson
McKinsey
AstraZeneca
Merck

Last Updated: September 23, 2020

DrugPatentWatch Database Preview

Patent: 8,383,103

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,383,103
Title:Botulinum toxin compositions and methods
Abstract: Disclosed herein are methods of using extracellular matrix digesting enzymes and neurotoxins, such as a Clostridial neurotoxins, to treat various medical conditions, such as overactive bladder, benign prostatic hyperplasia, hyperhidrosis, and cholecystitis for example.
Inventor(s): Gaylis; Franklin D. (La Mesa, CA), Blumenfeld; Andrew M. (Del Mar, CA)
Assignee: Allergan, Inc. (Irvine, CA) Gaylis; Franklin D. (La Mesa, CA)
Application Number:12/032,057
Patent Claims:see list of patent claims

Details for Patent 8,383,103

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bausch And Lomb VITRASE hyaluronidase INJECTABLE;INJECTION 021640 001 2004-12-21   Start Trial Allergan, Inc. (Irvine, CA) Gaylis; Franklin D. (La Mesa, CA) 2027-02-15 RX search
Bausch And Lomb VITRASE hyaluronidase INJECTABLE;INJECTION 021640 002 2004-12-21   Start Trial Allergan, Inc. (Irvine, CA) Gaylis; Franklin D. (La Mesa, CA) 2027-02-15 RX search
Amphastar Pharm AMPHADASE hyaluronidase INJECTABLE;INJECTION 021665 001 2005-11-03   Start Trial Allergan, Inc. (Irvine, CA) Gaylis; Franklin D. (La Mesa, CA) 2027-02-15 RX search
Akorn Inc HYDASE hyaluronidase INJECTABLE;INJECTION 021716 001 2005-10-25   Start Trial Allergan, Inc. (Irvine, CA) Gaylis; Franklin D. (La Mesa, CA) 2027-02-15 DISCN search
Smith And Nephew SANTYL collagenase OINTMENT;TOPICAL 101995 001 1965-06-04   Start Trial Allergan, Inc. (Irvine, CA) Gaylis; Franklin D. (La Mesa, CA) 2027-02-15 RX search
Elan Pharm MYOBLOC botulinum toxin type b VIAL 103846 001 2000-12-08   Start Trial Allergan, Inc. (Irvine, CA) Gaylis; Franklin D. (La Mesa, CA) 2027-02-15 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Colorcon
McKesson
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.